Search research articles
Contact Us
Filters
Showing results (41-50 of 366) with videos related to
Page
of 37
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1981
High-dose dexamethasone for prevention of cis-platin-induced vomiting
M S Aapro, D S Alberts
Seminars in Oncology
|
April 1, 1994
Total platinum dose versus platinum dose intensification in ovarian cancer treatment
D S Alberts, D J Garcia
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1991
Intraperitoneal therapy in ovarian cancer: time's not up
F M Muggia, D S Alberts
Cancer Treatment Reports
|
November 1, 1981
Pharmacologic antidotes to experimental doxorubicin skin toxicity: a suggested role for beta-adrenergic compounds
R T Dorr, D S Alberts
Investigational New Drugs
|
January 1, 1984
Phase II trial of mitoxantrone in head and neck cancer
M S Aapro, D S Alberts
Cancer
|
August 15, 1992
Topical absorption and inactivation of cytotoxic anticancer agents in vitro
R T Dorr, D S Alberts
Anti-Cancer Drugs
|
June 1, 1995
Cisplatin-associated neurotoxicity: can it be prevented?
D S Alberts, J K Noel
Arizona Medicine
|
February 1, 1979
Non-invasive scanning techniques for gynecologic cancer
C H Nash, D S Alberts
Investigational New Drugs
|
January 1, 1983
Skin ulceration potential without therapeutic anticancer activity for epipodophyllotoxin commercial diluents
R T Dorr, D S Alberts
Medical and Pediatric Oncology
|
January 1, 1978
Safe, rapid administration schedule for cis-platinum-mannitol
J M Rainey, D S Alberts
Page
of 37
Search research articles
Search
Showing results (41-50 of 366) with videos related to
Sort By:
Page
of 37
Cancer Chemotherapy and Pharmacology
|
January 1, 1981
High-dose dexamethasone for prevention of cis-platin-induced vomiting
M S Aapro, D S Alberts
Seminars in Oncology
|
April 1, 1994
Total platinum dose versus platinum dose intensification in ovarian cancer treatment
D S Alberts, D J Garcia
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1991
Intraperitoneal therapy in ovarian cancer: time's not up
F M Muggia, D S Alberts
Cancer Treatment Reports
|
November 1, 1981
Pharmacologic antidotes to experimental doxorubicin skin toxicity: a suggested role for beta-adrenergic compounds
R T Dorr, D S Alberts
Investigational New Drugs
|
January 1, 1984
Phase II trial of mitoxantrone in head and neck cancer
M S Aapro, D S Alberts
Cancer
|
August 15, 1992
Topical absorption and inactivation of cytotoxic anticancer agents in vitro
R T Dorr, D S Alberts
Anti-Cancer Drugs
|
June 1, 1995
Cisplatin-associated neurotoxicity: can it be prevented?
D S Alberts, J K Noel
Arizona Medicine
|
February 1, 1979
Non-invasive scanning techniques for gynecologic cancer
C H Nash, D S Alberts
Investigational New Drugs
|
January 1, 1983
Skin ulceration potential without therapeutic anticancer activity for epipodophyllotoxin commercial diluents
R T Dorr, D S Alberts
Medical and Pediatric Oncology
|
January 1, 1978
Safe, rapid administration schedule for cis-platinum-mannitol
J M Rainey, D S Alberts
Page
of 37